Epilepsy and dendritic excitability

癫痫和树突状兴奋性

基本信息

  • 批准号:
    9890005
  • 负责人:
  • 金额:
    $ 33.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are voltage-gated ion channels that modulate excitability in several brain regions involved in the pathogenesis of epilepsy, including the hippocampus, neocortex, and thalamus. Accumulated evidence shows that downregulation of Ih, the current generated by HCN channels, causes neuronal hyperexcitability, and that genetic deletion of HCN1 channels, the main cortical and hippocampal subtype, accelerates the rate of epileptogenesis in acquired epilepsy models. More recent evidence shows that mutations in HCN1 underlie early life epileptic encephalopathy in some children with severe epilepsy and developmental delay. Thus HCN1 channelopathy occurs in both human genetic epilepsy and animal models of acquired epilepsy. In recent work from our laboratory, epilepsy induced by chemoconvulsant-induced status epilepticus (SE) was associated with loss of HCN1 channel expression that began within 1 hour post-SE, and persisted into chronic epilepsy. HCN1 channels were acutely internalized from the surface membrane of hippocampal pyramidal dendrites within the first hour following SE, well before the onset several days later of transcriptional downregulation of HCN1 mRNA expression. We now show for the first time that HCN1 channel surface expression is governed in a bidirectional fashion by protein kinase C (PKC) activity, with increased phosphorylation of HCN1 by PKC leading to decreased HCN1 surface expression. New preliminary data using mass spectrometry techniques show that HCN1 channels are minimally phosphorylated at rest, but undergo increased phosphorylation at S867 and S868 residues, which are also phosphorylated in naive tissue under conditions of PKC activation. These data suggest that the earliest manifestation of HCN1 channels dysfunction during epileptogenesis is PKC-mediated loss of surface expression and concomitant loss of HCN1-mediated current (Ih). Our goal in this R01 renewal application is to further understand the mechanisms of HCN1 channel dysfunction during the development of epilepsy. We propose to further study the phosphorylation signaling mechanisms underlying acute changes in HCN1 membrane trafficking after SE; determine whether these early events contribute to or initiate chronic HCN1 channelopathy; and characterize the effects of human HCN1 mutations on HCN1 channel biophysical properties. To do so, we will use state-of-the-art techniques including: mass spectrometry; viral transduction of mutant HCN1 channel expression in vivo; cellular electrophysiology in the dendrites of CA1 hippocampal pyramidal neurons; and analysis of a novel dataset of HCN1 mutations in a cohort of 800 children affected with epileptic encephalopathy of unknown cause.
 描述(由申请人提供):超极化激活的环核苷酸门控(HCN)通道是电压门控离子通道,可调节参与癫痫发病机制的多个大脑区域的兴奋性,包括海马体、新皮质和丘脑。积累的证据表明,HCN 通道产生的电流 Ih 的下调会导致神经元过度兴奋,而 HCN1 通道(主要皮质和海马亚型)的基因缺失会加速获得性癫痫模型中的癫痫发生率。最近的证据表明,HCN1 突变是一些患有严重癫痫和发育迟缓的儿童早期癫痫性脑病的基础。因此,HCN1 通道病发生在人类遗传性癫痫和获得性癫痫的动物模型中。 在我们实验室最近的研究中,化学惊厥诱发的癫痫持续状态 (SE) 引起的癫痫与 SE 后 1 小时内开始的 HCN1 通道表达丧失相关,并持续发展为慢性癫痫。在 SE 后的第一个小时内,HCN1 通道从海马锥体树突的表面膜急剧内化,远早于几天后 HCN1 mRNA 表达转录下调的开始。我们现在首次表明,HCN1 通道表面表达受到蛋白激酶 C (PKC) 活性的双向控制,PKC 对 HCN1 的磷酸化增加导致 HCN1 表面表达减少。使用质谱技术的新初步数据表明,HCN1 通道在静止时磷酸化程度最低,但在 S867 和 S868 残基处磷酸化增加,在 PKC 激活条件下,这些残基在初始组织中也会磷酸化。这些数据表明,癫痫发生过程中 HCN1 通道功能障碍的最早表现是 PKC 介导的表面表达丧失以及伴随的 HCN1 介导的电流 (Ih) 丧失。 我们在 R01 更新应用中的目标是进一步了解癫痫发展过程中 HCN1 通道功能障碍的机制。我们建议进一步研究 SE 后 HCN1 膜运输急性变化背后的磷酸化信号机制;确定这些早期事件是否导致或引发慢性 HCN1 通道病变;并表征人类 HCN1 突变对 HCN1 通道生物物理特性的影响。为此,我们将使用最先进的技术,包括:质谱分析;体内突变HCN1通道表达的病毒转导; CA1 海马锥体神经元树突的细胞电生理学;对 800 名不明原因癫痫性脑病儿童的 HCN1 突变新数据集进行分析。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dephosphorylation proves detrimental to GABAergic inhibition.
去磷酸化被证明对 GABA 能抑制有害。
  • DOI:
    10.5698/1535-7511-12.1.22
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Poolos,NicholasP
  • 通讯作者:
    Poolos,NicholasP
HCN Channel Phosphorylation Sites Mapped by Mass Spectrometry in Human Epilepsy Patients and in an Animal Model of Temporal Lobe Epilepsy.
  • DOI:
    10.1016/j.neuroscience.2021.01.038
  • 发表时间:
    2021-04-15
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Concepcion FA;Khan MN;Ju Wang JD;Wei AD;Ojemann JG;Ko AL;Shi Y;Eng JK;Ramirez JM;Poolos NP
  • 通讯作者:
    Poolos NP
Antiepileptic action of c-Jun N-terminal kinase (JNK) inhibition in an animal model of temporal lobe epilepsy.
  • DOI:
    10.1016/j.neuroscience.2017.02.024
  • 发表时间:
    2017-05-04
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Tai TY;Warner LN;Jones TD;Jung S;Concepcion FA;Skyrud DW;Fender J;Liu Y;Williams AD;Neumaier JF;D'Ambrosio R;Poolos NP
  • 通讯作者:
    Poolos NP
Genetic loss of HCN1 channels is exciting, but is it epileptic?
HCN1 通道的遗传缺失令人兴奋,但它会导致癫痫吗?
  • DOI:
    10.1111/j.1535-7511.2009.01352.x
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Poolos,NicholasP
  • 通讯作者:
    Poolos,NicholasP
Rapid loss of dendritic HCN channel expression in hippocampal pyramidal neurons following status epilepticus.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS P POOLOS其他文献

NICHOLAS P POOLOS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS P POOLOS', 18)}}的其他基金

Antiepileptic action of JNK2 inhibition
JNK2 抑制的抗癫痫作用
  • 批准号:
    10515751
  • 财政年份:
    2022
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    8298536
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    8494098
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    7812548
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    7779790
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    7082008
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    8039897
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    9125570
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    9257467
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:
Epilepsy and dendritic excitability
癫痫和树突状兴奋性
  • 批准号:
    6986248
  • 财政年份:
    2005
  • 资助金额:
    $ 33.8万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.8万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了